Annual Total Liabilities
$5.86 M
-$2.32 M-28.40%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual total liabilities is $5.86 million, with the most recent change of -$2.32 million (-28.40%) on December 31, 2023.
- During the last 3 years, MTNB annual total liabilities has fallen by -$1.38 million (-19.05%).
- MTNB annual total liabilities is now -33.67% below its all-time high of $8.83 million, reached on December 31, 2021.
Performance
MTNB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.80 M
-$464.00 K-8.82%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly total liabilities is $4.80 million, with the most recent change of -$464.00 thousand (-8.82%) on September 30, 2024.
- Over the past year, MTNB quarterly total liabilities has dropped by -$1.84 million (-27.75%).
- MTNB quarterly total liabilities is now -49.85% below its all-time high of $9.57 million, reached on June 30, 2022.
Performance
MTNB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MTNB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.4% | -27.8% |
| 3 y3 years | -19.1% | -27.8% |
| 5 y5 years | +54.1% | -27.8% |
MTNB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.7% | at low | -49.9% | at low |
| 5 y | 5-year | -33.7% | at low | -49.9% | at low |
| alltime | all time | -33.7% | +582.0% | -49.9% | +569.2% |
Matinas BioPharma Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.80 M(-8.8%) |
| Jun 2024 | - | $5.26 M(+4.2%) |
| Mar 2024 | - | $5.05 M(-13.8%) |
| Dec 2023 | $5.86 M(-28.4%) | $5.86 M(-11.8%) |
| Sep 2023 | - | $6.64 M(+7.6%) |
| Jun 2023 | - | $6.17 M(+9.5%) |
| Mar 2023 | - | $5.64 M(-31.1%) |
| Dec 2022 | $8.18 M(-7.4%) | $8.18 M(-8.3%) |
| Sep 2022 | - | $8.93 M(-6.7%) |
| Jun 2022 | - | $9.57 M(+18.1%) |
| Mar 2022 | - | $8.10 M(-8.3%) |
| Dec 2021 | $8.83 M(+22.0%) | $8.83 M(+1.2%) |
| Sep 2021 | - | $8.73 M(+23.5%) |
| Jun 2021 | - | $7.07 M(+22.0%) |
| Mar 2021 | - | $5.79 M(-19.9%) |
| Dec 2020 | $7.24 M(+0.7%) | $7.24 M(+9.6%) |
| Sep 2020 | - | $6.60 M(+5.4%) |
| Jun 2020 | - | $6.26 M(-3.8%) |
| Mar 2020 | - | $6.51 M(-9.4%) |
| Dec 2019 | $7.19 M | $7.19 M(+5.2%) |
| Sep 2019 | - | $6.84 M(-12.3%) |
| Jun 2019 | - | $7.80 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $7.57 M(+99.0%) |
| Dec 2018 | $3.80 M(+1.6%) | $3.80 M(-7.5%) |
| Sep 2018 | - | $4.11 M(+16.9%) |
| Jun 2018 | - | $3.52 M(+15.1%) |
| Mar 2018 | - | $3.06 M(-18.3%) |
| Dec 2017 | $3.74 M(+40.3%) | $3.74 M(+0.1%) |
| Sep 2017 | - | $3.74 M(+44.3%) |
| Jun 2017 | - | $2.59 M(-18.3%) |
| Mar 2017 | - | $3.17 M(+19.0%) |
| Dec 2016 | $2.67 M(+14.3%) | $2.67 M(+3.2%) |
| Sep 2016 | - | $2.58 M(+0.7%) |
| Jun 2016 | - | $2.57 M(+1.7%) |
| Mar 2016 | - | $2.53 M(+8.2%) |
| Dec 2015 | $2.33 M(+105.9%) | $2.33 M(-19.7%) |
| Sep 2015 | - | $2.91 M(-10.1%) |
| Jun 2015 | - | $3.23 M(-5.0%) |
| Mar 2015 | - | $3.40 M(+200.4%) |
| Dec 2014 | $1.13 M(+32.0%) | $1.13 M(+8.7%) |
| Sep 2014 | - | $1.04 M(+15.2%) |
| Jun 2014 | - | $905.80 K(+26.3%) |
| Mar 2014 | - | $717.00 K(-16.5%) |
| Dec 2013 | $859.00 K | $859.00 K |
FAQ
- What is Matinas BioPharma Holdings annual total liabilities?
- What is the all time high annual total liabilities for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual total liabilities year-on-year change?
- What is Matinas BioPharma Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly total liabilities year-on-year change?
What is Matinas BioPharma Holdings annual total liabilities?
The current annual total liabilities of MTNB is $5.86 M
What is the all time high annual total liabilities for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual total liabilities is $8.83 M
What is Matinas BioPharma Holdings annual total liabilities year-on-year change?
Over the past year, MTNB annual total liabilities has changed by -$2.32 M (-28.40%)
What is Matinas BioPharma Holdings quarterly total liabilities?
The current quarterly total liabilities of MTNB is $4.80 M
What is the all time high quarterly total liabilities for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly total liabilities is $9.57 M
What is Matinas BioPharma Holdings quarterly total liabilities year-on-year change?
Over the past year, MTNB quarterly total liabilities has changed by -$1.84 M (-27.75%)